HAMP and cancer: Several studies have reported that circulating iron restriction caused by inflammation-induced hepcidin activation promotes ineffective erythropoiesis and results in anemia of inflammation, a form of anemia commonly associated with chronic inflammatory conditions such as cancer and CKD [37–41].